表紙
市場調査レポート

CountryFocus:ベトナムの医療・規制・医療費償還制度の情勢

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Vietnam

発行 GlobalData 商品コード 304731
出版日 ページ情報 英文 147 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
CountryFocus:ベトナムの医療・規制・医療費償還制度の情勢 CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Vietnam
出版日: 2016年07月01日 ページ情報: 英文 147 Pages
概要

当レポートでは、ベトナムの医療・規制・医療費償還制度について調査分析し、医薬品・医療機器市場の概要、医療費償還制度とその関連情報、規制当局の構造や規制の概要、国の情勢について検証するほか、市場機会や課題などについて、体系的な情報を提供しています。

第1章 目次

第2章 イントロダクション

第3章 医薬品・医療機器市場の概要

  • 医薬品市場
  • 医療機器市場
  • 市場促進要因・障壁

第4章 市場参入

  • 医療費償還・保険料払込者の情勢
  • 規制情勢

第5章 国の分析

  • 政策環境
  • 経済情勢
  • 経済指標
  • 人口統計
  • 医療インフラ
  • 産業団体
  • 見本市

第6章 機会と課題

  • 機会
  • 課題

第7章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC0061CHR

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Vietnam". It is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Vietnam, identifying key trends in the healthcare market and providing insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices market, using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData's team of industry experts.

In 2015, Vietnam's population stood at 92 million, an increase from 85 million in 2008 due to the high birth rate and low mortality rate. The country's pharmaceutical market was estimated to have been worth $3.5 billion in 2015 and is expected to reach $6.6 billion by 2020 at a projected Compound Annual Growth Rate (CAGR) of 13.8%. The medical device market was estimated at approximately $295m in 2015 and is expected to grow at a CAGR of 11.3% to $505m by 2020.

The positive trends in Vietnam's healthcare market can primarily be attributed to -

  • Increasing coverage of healthcare insurance
  • Government initiatives to improve healthcare facilities

Scope

The report includes -

  • Overview of the pharmaceutical and medical device markets, including size, segmentation and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Sanofi, Hau Giang Pharmaceuticals (DHG Pharmaceuticals), Imexpharm, Traphaco and Domesco.
  • An insightful review of the reimbursement and regulatory landscape, covering the healthcare reimbursement process, regulatory agencies, and the approval processes for new drugs and medical devices.
  • Detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to buy

The report will enhance your decision-making capability by allowing you to -

  • Develop business strategies through an understanding of the trends shaping and driving the healthcare market
  • Drive revenue by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical device market segments and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment and strategic partnership
  • Identify, understand and capitalize on the opportunities and challenges in the healthcare market

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. GlobalData Report Guidance

3. Overview of the Pharmaceutical and Medical Device Markets

  • 3.1. Pharmaceutical Market
    • 3.1.1. Market Overview
    • 3.1.2. Pharmaceutical Exports and Imports
    • 3.1.3. Supply Channels
    • 3.1.4. Market Segments
    • 3.1.5. Major Disease Areas
    • 3.1.6. Major Companies
  • 3.2. Medical Device Market
  • 3.3. Market Drivers and Barriers
    • 3.3.1. Drivers
    • 3.3.2. Barriers

4. Market Access

  • 4.1. Reimbursement and Payer Landscape
    • 4.1.1. Overview of Healthcare System
    • 4.1.2. Reimbursement Process
    • 4.1.3. Overview of Insurance Providers
    • 4.1.4. Patient Share in Healthcare Spending
    • 4.1.5. Price Trends in Healthcare Sector
    • 4.1.6. Pricing Policies
  • 4.2. Regulatory Landscape
    • 4.2.1. Overview of Regulatory Agencies
    • 4.2.2. Market Authorization Procedure for Pharmaceutical Products
    • 4.2.3. New Medical Device Approval Process
    • 4.2.4. Licensing Process for Pharmaceutical and Medical Device Manufacturing
    • 4.2.5. Licensing Process for Pharmaceutical Exports and Imports
    • 4.2.6. Intellectual Property Rights
    • 4.2.7. Clinical Trial Regulations
    • 4.2.8. Pharmaceutical Advertising Regulations
    • 4.2.9. Pharmacy Regulations
    • 4.2.10. Labeling and Packaging Regulations

5. Country Analysis

  • 5.1. Political Environment
    • 5.1.1. Political Structure
    • 5.1.2. Analysis of the Current Political Environment
    • 5.1.3. Healthcare Policy Initiatives
  • 5.2. Economic Landscape
  • 5.3. Economic Indicators
    • 5.3.1. Gross Domestic Product
    • 5.3.2. Gross National Income
    • 5.3.3. Inflation
    • 5.3.4. Currency Exchange Rate
    • 5.3.5. Foreign Direct Investment
    • 5.3.6. Foreign Exchange Reserves
    • 5.3.7. Trade Balance
    • 5.3.8. General Government Structural Balance
    • 5.3.9. General Government Net Debt
    • 5.3.10. Major Industries
  • 5.4. Demographics
    • 5.4.1. Population
    • 5.4.2. Education and Literacy
    • 5.4.3. Employment
    • 5.4.4. Disease Burden
  • 5.5. Healthcare Infrastructure
    • 5.5.1. Healthcare Facilities
    • 5.5.2. Healthcare Parameters
    • 5.5.3. Environmental Health
    • 5.5.4. Healthcare Personnel
  • 5.6. Healthcare Expenditure
    • 5.6.1. Overview
    • 5.6.2. Major Components of Healthcare Spending
    • 5.6.3. Public and Private Sector Share
    • 5.6.4. Spending in Healthcare R&D
  • 5.7. Trade Associations
    • 5.7.1. Vietnam Pharmaceutical Companies Association
    • 5.7.2. Vietnam General Association of Medicine and Pharmacy
    • 5.7.3. Vietnam Public Health Association
  • 5.8. Trade Fairs

6. Opportunities and Challenges

  • 6.1. Opportunities
  • 6.2. Challenges

7. Appendix

  • 7.1. Abbreviations
  • 7.2. Bibliography
  • 7.3. Research Methodology
    • 7.3.1. Coverage
    • 7.3.2. Secondary Research
    • 7.3.3. Forecasts
    • 7.3.4. Expert Panel
  • 7.4. Disclaimer

List of Tables

  • Table 1: Pharmaceutical Market, Vietnam, Revenue ($bn), 2008-2015
  • Table 2: Pharmaceutical Market, Vietnam, Revenue Forecast ($bn), 2016-2020
  • Table 3: Pharmaceutical Market, Vietnam, Exports and Imports ($m), 2008-2015
  • Table 4: Pharmaceutical Market, Vietnam, Generic Market Revenue ($bn), 2008-2015
  • Table 5: OTC Market, Vietnam, Revenue ($m), 2008-2015
  • Table 6: Pharmaceutical Market, Vietnam, Major Disease Areas, Prevalence and Number of Mental Disorder Cases, 2005
  • Table 7: Pharmaceutical Market, Sanofi, Major Products, 2015
  • Table 8: Pharmaceutical Market, Sanofi, Global, Late-Stage Pipeline, 2016
  • Table 9: Pharmaceutical Market, DHG Pharmaceutical, Major Products, 2015
  • Table 10: Pharmaceutical Market, Traphaco, Major Products, 2015
  • Table 11: Pharmaceutical Market, Domesco, Major Products, 2015
  • Table 12: Medical Device Market, Vietnam, Revenue ($m), 2008-2015
  • Table 13: Medical Device Market, Vietnam, Revenue ($m), 2016-2020
  • Table 14: Market Access, Vietnam, Health Insurance Population Coverage (%), 2008-2015
  • Table 15: Market Access, Vietnam, Out-of-Pocket Expenditure (%), 2008-2015
  • Table 16: Market Access, Vietnam, Change in Average Price of Healthcare Services (%), 2008-2015
  • Table 17: Regulatory Landscape, Vietnam, Trademark Filing Fees and Charges, 2015
  • Table 18: Regulatory Landscape, Vietnam, Labeling Guidelines, 2015
  • Table 19: Economic Indicators, Vietnam, GDP per Capita ($), 2008-2015
  • Table 20: Economic Indicators, Vietnam, GDP per Capita Forecast ($), 2016-2020
  • Table 21: Economic Indicators, Vietnam, GDP Annual Growth (%), 2008-2015
  • Table 22: Economic Indicators, Vietnam, GDP Annual Growth (%), 2016-2020
  • Table 23: Economic Indicators, Vietnam, GNI Per Capita ($), 2008-2015
  • Table 24: Economic Indicators, Vietnam, Consumer Price Index, 2008-2015
  • Table 25: Economic Indicators, Vietnam, Consumer Price Index, 2016-2020
  • Table 26: Economic Indicators, Vietnam, Consumer Price Annual Change (%), 2008-2015
  • Table 27: Economic Indicators, Vietnam Currency Exchange Rate ($/VND) 2008-2015
  • Table 28: Economic Indicators, Vietnam, FDI ($bn), 2008-2015
  • Table 29: Economic Indicators, Vietnam, Foreign Exchange Reserves ($bn), 2008-2015
  • Table 30: Economic Indicators, Vietnam, Imports of Goods and Services ($bn), 2008-2015
  • Table 31: Economic Indicators, Vietnam, Exports of Goods and Services ($bn), 2008-2015
  • Table 32: Economic Indicators, Vietnam, Government Structural Balance ($bn), 2008-2015
  • Table 33: Economic Indicators, Vietnam, General Government Net Debt ($bn), 2008-2015
  • Table 34: Economic Indicators, Vietnam, General Government Net Debt Forecast ($bn), 2016-2020
  • Table 35: Economic Indicators, Vietnam, Major Industries, Population Employed (million), 2014
  • Table 36: Demographics, Vietnam, Population (million), 2008-2015
  • Table 37: Demographics, Vietnam, Population (million), 2016-2020
  • Table 38: Demographics, Vietnam, Population, Urban and Rural Population Share (%), 2008-2015
  • Table 39: Demographics, Vietnam, Population, Urban and Rural Population Share Forecast (%), 2016-2020
  • Table 40: Demographics, Vietnam, Population Distribution by Age Group (%), 2008-2015
  • Table 41: Demographics, Vietnam, Population Distribution by Age Group Forecast (%), 2016-2020
  • Table 42: Demographics, Vietnam, Births (per 1,000 population), 2008-2015
  • Table 43: Demographics, Vietnam, Mortality (per 1,000 population), 2008-2015
  • Table 44: Demographics, Vietnam, Major Causes of Mortality, Number of Deaths (%), 2011
  • Table 45: Demographics, Vietnam, Children under Five, Mortality Rate (per 1,000 live births), 2008-2015
  • Table 46: Demographics, Vietnam, Immunization Rate (%), 2008-2013
  • Table 47: Demographics, Vietnam, Major Causes of Male Mortality, Number of Cases ('000), 2011
  • Table 48: Demographics, Vietnam, Major Causes of Female Mortality ('000), 2011
  • Table 49: Demographics, Vietnam, Gender Ratio (M/F), 2008-2015
  • Table 50: Demographics, Vietnam, Life Expectancy at Birth (years), 2008-2015
  • Table 51: Demographics, Vietnam, Gross Enrollment by Level of Education (%), 2008-2015
  • Table 52: Demographics, Vietnam, Unemployment Rate (%), 2008-2015
  • Table 53: Demographics, Vietnam, Number of Deaths by Disease ('000), 2013
  • Table 54: Demographics, Vietnam, Major Diseases, DALYs ('000), 2012
  • Table 55: Healthcare Infrastructure, Vietnam, Health Establishments, 2008-2015
  • Table 56: Healthcare Infrastructure, Vietnam, Number of Beds by Type of Establishment, 2008-2015
  • Table 57: Healthcare Infrastructure, Vietnam, Hospital Beds (per 1,000 population), 2008-2015
  • Table 58: Healthcare Infrastructure, Vietnam, Doctors (per 1,000 population), 2008-2015
  • Table 59: Healthcare Infrastructure, Vietnam, PM2.5 (µg/m3), 2008-2015
  • Table 60: Healthcare Infrastructure, Vietnam, CO2 Emissions (metric tons per capita), 2008-2015
  • Table 61: Healthcare Infrastructure, Vietnam, Nurses (per 1,000 population), 2008-2015
  • Table 62: Healthcare Infrastructure, Vietnam, Midwives (per 1,000 population), 2008-2015
  • Table 63: Healthcare Infrastructure, Vietnam, Pharmacists (per 1,000 population), 2008-2015
  • Table 64: Healthcare Expenditure, Vietnam, Healthcare Expenditure (% of GDP), 2008-2015
  • Table 65: Healthcare Expenditure, Vietnam, Public Healthcare Expenditure, Share of Major Components (%), 2013
  • Table 66: Healthcare Expenditure, Vietnam, Healthcare Expenditure, Public-Private Share (%), 2008-2015
  • Table 67: Healthcare Expenditure, Vietnam, Major Healthcare Trade Fairs, 2016

List of Figures

  • Figure 1: Pharmaceutical Market, Vietnam, Revenue ($bn), 2008-2015
  • Figure 2: Pharmaceutical Market, Vietnam, Revenue Forecast ($bn), 2016-2020
  • Figure 3: Pharmaceutical Market, Vietnam, Exports and Imports ($m), 2008-2015
  • Figure 4: Pharmaceutical Market, Vietnam, Supply Chain, 2015
  • Figure 5: Pharmaceutical Market, Vietnam, Distribution channels, 2015
  • Figure 6: Pharmaceutical Market, Vietnam, Generic Market Revenue ($bn), 2008-2015
  • Figure 7: Pharmaceutical Market, Vietnam, OTC Market Revenue ($bn), 2008-2015
  • Figure 8: Medical Device Market, Vietnam, Revenue ($m), 2008-2015
  • Figure 9: Medical Device Market, Vietnam, Revenue ($m), 2016-2020
  • Figure 10: Healthcare Market, Vietnam, Drivers and Barriers, 2016
  • Figure 11: Market Access, Vietnam, Overview of Healthcare System
  • Figure 12: Market Access, Vietnam, Overview of Healthcare System
  • Figure 13: Market Access, Vietnam, Health Insurance Population Coverage (%), 2008-2015
  • Figure 14: Market Access, Vietnam, Out-of-Pocket Expenditure (%), 2008-2015
  • Figure 15: Market Access, Vietnam, Change in Average Price of Healthcare Services (%), 2008-2015
  • Figure 16: Market Access, Vietnam, Marketing Authorization Procedure, 2015
  • Figure 17: Regulatory Landscape, Vietnam, Generic Drug Approval Process, 2015
  • Figure 18: Market Access, Vietnam, Patent Approval Process, 2014
  • Figure 19: Economic Indicators, Vietnam, GDP per Capita ($), 2008-2015
  • Figure 20: Economic Indicators, Vietnam, GDP per Capita ($), 2016-2020
  • Figure 21: Economic Indicators, Vietnam, GDP Annual Growth (%), 2008-2015
  • Figure 22: Economic Indicators, Vietnam, GDP Annual Growth (%), 2016-2020
  • Figure 23: Economic Indicators, Vietnam, GNI Per Capita ($), 2008-2015
  • Figure 24: Economic Indicators, Vietnam, Consumer Price Index, 2008-2015
  • Figure 25: Economic Indicators, Vietnam, Consumer Price Index, 2016-2020
  • Figure 26: Economic Indicators, Vietnam, Consumer Price Annual Change (%), 2008-2015
  • Figure 27: Economic Indicators, Vietnam, Currency Exchange Rate ($/VND) 2008-2015
  • Figure 28: Economic Indicators, Vietnam, FDI ($bn), 2008-2015
  • Figure 29: Economic Indicators, Vietnam, Foreign Exchange Reserves ($bn), 2008-2015
  • Figure 30: Economic Indicators, Vietnam, Imports of Goods and Services ($bn), 2008-2015
  • Figure 31: Economic Indicators, Vietnam, Exports of Goods and Services ($bn), 2008-2015
  • Figure 32: Economic Indicators, Vietnam, Government Structural Balance ($bn), 2008-2015
  • Figure 33: Economic Indicators, Vietnam, General Government Net Debt ($bn), 2008-2015
  • Figure 34: Economic Indicators, Vietnam, General Government Net Debt ($bn), 2016-2020
  • Figure 35: Economic Indicators, Vietnam, Major Industries, Population Employed (million), 2014
  • Figure 36: Demographics, Vietnam, Population (million), 2008-2015
  • Figure 37: Demographics, Vietnam, Population (million), 2016-2020
  • Figure 38: Demographics, Vietnam, Population, Urban and Rural Population Share (%), 2008-2015
  • Figure 39: Demographics, Vietnam, Population, Urban and Rural Population Share (%), 2016-2020
  • Figure 40: Demographics, Vietnam, Population Distribution by Age Group (%), 2008-2015
  • Figure 41: Demographics, Vietnam, Population Distribution by Age Group (%), 2016-2020
  • Figure 42: Demographics, Vietnam, Births (per 1,000 population), 2008-2015
  • Figure 43: Demographics, Vietnam, Mortality (per 1,000 population), 2008-2015
  • Figure 44: Demographics, Vietnam, Major Causes of Mortality, Number of Deaths (%), 2011
  • Figure 45: Demographics, Vietnam, Children under Five, Mortality Rate (per 1,000 live births), 2008-2015
  • Figure 46: Demographics, Vietnam, Immunization Rate (%), 2008-2015
  • Figure 47: Demographics, Vietnam, Major Causes of Male Mortality, Number of Cases ('000), 2011
  • Figure 48: Demographics, Vietnam, Major Causes of Female Mortality, Number of Cases ('000), 2011
  • Figure 49: Demographics, Vietnam, Gender Ratio (M/F), 2008-2015
  • Figure 50: Demographics, Vietnam, Life Expectancy at Birth (years), 2008-2015
  • Figure 51: Demographics, Vietnam, Gross Enrollment by Level of Education (%), 2008-2015
  • Figure 52: Demographics, Vietnam, Unemployment Rate (%), 2008-2015
  • Figure 53: Demographics, Vietnam, Number of Cases by Disease ('000), 2012
  • Figure 54: Demographics, Vietnam, Major Diseases, DALYs ('000), 2012
  • Figure 55: Healthcare Infrastructure, Vietnam, Health Establishments, 2008-2015
  • Figure 56: Healthcare Infrastructure, Vietnam, Number of Beds by Type of Establishment, 2008-2015
  • Figure 57: Healthcare Infrastructure, Vietnam, Hospital Beds (per 1,000 population), 2008-2015
  • Figure 58: Healthcare Infrastructure, Vietnam, Doctors (per 1,000 population), 2008-2015
  • Figure 59: Healthcare Infrastructure, Vietnam, PM2.5 (µg/m3), 2008-2015
  • Figure 60: Healthcare Infrastructure, Vietnam, CO2 Emissions (metric tons per capita), 2008-2015
  • Figure 61: Healthcare Infrastructure, Vietnam, Nurses (per 1,000 population), 2008-2015
  • Figure 62: Healthcare Infrastructure, Vietnam, Midwives (per 1,000 population), 2008-2015
  • Figure 63: Healthcare Infrastructure, Vietnam, Pharmacists (per 1,000 population), 2008-2015
  • Figure 64: Healthcare Expenditure, Vietnam, Healthcare Expenditure (% of GDP), 2008-2015
  • Figure 65: Healthcare Expenditure, Vietnam, Public Healthcare Expenditure, Share of Major Components (%), 2013
  • Figure 66: Healthcare Expenditure, Vietnam, Public-Private Share of Healthcare Expenditure (%), 2008-2015
  • Figure 67: Healthcare Market, Vietnam, Opportunities and Challenges, 2016
Back to Top